Efficacy of Second-line Chemotherapy in Patients With Sensitive Relapsed Small-cell Lung Cancer

Background/Aim: To evaluate treatment efficacy of cisplatin, etoposide, and irinotecan combined therapy (PEI), platinum-rechallenge chemotherapy (Pt-Re) and amrubicin monotherapy (AMR) for patients with sensitive relapsed small cell lung cancer (SCLC). Patients and Methods: We defined sensitive rela...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :In Vivo
Главные авторы: WAKUDA, KAZUSHIGE, MIYAWAKI, TAICHI, MIYAWAKI, ERIKO, MAMESAYA, NOBUAKI, KAWAMURA, TAKAHISA, KOBAYASHI, HARUKI, OMORI, SHOTA, NAKASHIMA, KAZUHISA, ONO, AKIRA, KENMOTSU, HIROTSUGU, NAITO, TATEAKI, MURAKAMI, HARUYASU, MORI, KEITA, ENDO, MASAHIRO, TAKAHASHI, TOSHIAKI
Формат: Artigo
Язык:Inglês
Опубликовано: International Institute of Anticancer Research 2019
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6899092/
https://ncbi.nlm.nih.gov/pubmed/31662561
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.11727
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы